Sort
15,842 grants matching “pancreatic cancer”
Listeria Immunotherapy for Pancreatic and Ovarian Cancer
$332,770Thomas W. Dubensky · Cerus Corporation · R44 · FY2006 · CA
Mechanisms of durable antitumor immunity via CD26hiCD4+ T cells
$332,709Chrystal Mary Paulos · Medical University Of South Carolina · R01 · FY2019 · CA
The CD226 and TIGIT Costimulatory Axis in Type 1 Diabetes
$332,654Todd Michael Brusko · University Of Florida · R01 · FY2016 · DK
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer
$332,649Min Li · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2019 · CA
TNF Blockade in Pancreatic Cancer Patients
$332,638Ohio State University · R21 · FY2004 · CA
TNF Blockade in Pancreatic Cancer Patients
$332,638Ohio State University · R21 · FY2003 · CA
Project 1:Improving Pancreatic Risk Assessment
$332,606Alison P Klein · Johns Hopkins University · P50 · FY2019 · CA
Project 1:Improving Pancreatic Risk Assessment
$332,605Alison P Klein · Johns Hopkins University · P50 · FY2022 · CA
Targeting Akt/NF-kappa beta for Pancreatic Cancer Therapy
$332,571Wayne State University · R01 · FY2004 · CA
Targeting Akt/NF-kappa beta for Pancreatic Cancer Therapy
$332,571Wayne State University · R01 · FY2003 · CA
Defining the Role of BPTF Epigenetic Reader Domains in Cancer
$332,551William Charles Krause Pomerantz · University Of Minnesota · R01 · FY2017 · GM
The RAP80-BRCC36 Deubiquitinating Complex in DNA Repair
$332,509Roger A Greenberg · University Of Pennsylvania · R01 · FY2015 · CA
Targeting NAD Catabolism in Pancreatic Cancer Cells: Role of Small Molecule SIRT
$332,445Eduardo N Chini · Mayo Clinic Rochester · P50 · FY2018 · CA
The CD226 and TIGIT Costimulatory Axis in Type 1 Diabetes
$332,411Todd Michael Brusko · University Of Florida · R01 · FY2017 · DK
Development of Targeted Nanotechnology Platform for Pancreatic Cancer
$332,374Subhash C. Chauhan · University Of Texas Rio Grande Valley · R01 · FY2021 · CA
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism
$332,357Deepak Nagrath · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
MUC1 in Therapy Resistance
$332,343Michael A Hollingsworth · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2022 · CA
Targeting MARK2-HDAC signaling to overcome paclitaxel resistance in pancreatic cancer
$332,343Jixin Dong · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2022 · CA
Lineage specifiers governing pancreatic cancer growth and molecular subtype
$332,209Eric Lee Snyder · University Of Utah · R01 · FY2024 · CA
The CD226 and TIGIT Costimulatory Axis in Type 1 Diabetes
$332,157Todd Michael Brusko · University Of Florida · R01 · FY2018 · DK
Determinants of AGR2 effects in Barrett's esophagus and esophageal adenocarcinoma
$332,032Anson W Lowe · Stanford University · R01 · FY2008 · DK
Novel Theranostics for Pancreatic Cancer
$332,031Julia Davydova · University Of Minnesota · R01 · FY2014 · CA
Mechanisms of Pancreatic Inflammation, Tissue Repair and Carcinogenesis
$332,022Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
Molecular Mediators of Pancreatic Cancer Invasion and Progression
$332,000Keping Xie · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA
Molecular Mediators of Pancreatic Cancer Invasion and Progression
$332,000Keping Xie · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA